Comparative Study: Biguanide-, Sulfonamide-, and Natural Agent-Based Interventions in an In Vivo Experimental...

Area of Science:

• Pharmacology
• Endocrinology
• Metabolic Disorders

Background:

• Diabetes mellitus is a complex metabolic disorder requiring effective management.
• Current treatments like metformin have limitations, necessitating exploration of novel therapeutic strategies.
• Investigating adjunct therapies, including natural products, is crucial for improving glycemic control.

Purpose of the Study:

• To evaluate the hypoglycemic effects of a synthetic sulfonamide (S) alone and combined with Salvia officinalis extract.
• To compare the efficacy of S and its combination with Salvia officinalis against metformin in an in vivo diabetes model.
• To analyze the pharmacokinetic properties of S and metformin and their correlation with glycemic response.

Main Methods:

• Alloxan-induced diabetes model in Wistar female rats.
• Six experimental groups, including healthy controls and untreated diabetic controls.
• Quantification of plasma metformin and sulfonamide concentrations using high-performance liquid chromatography (HPLC).

Main Results:

• The combination of synthetic sulfonamide (S) and Salvia officinalis extract achieved the highest blood glucose reduction (50.2%).
• S alone (40.6%) and metformin (36.4%) also showed significant hypoglycemic effects compared to untreated controls (p < 0.05).
• Synthetic sulfonamide S exhibited a larger volume of distribution than metformin; no significant correlation between plasma drug levels and glycemic response was observed.

Conclusions:

• Combining synthetic sulfonamide (S) with Salvia officinalis extract offers superior glycemic control compared to monotherapy or metformin.
• This study provides the first in vivo evidence for the synergistic hypoglycemic effects of a sulfonylurea-type compound and Salvia officinalis extract.
• Natural alternatives like Salvia officinalis hold promise for complementary mechanisms in managing diabetes.